Morbid obesity
1 paper
Trial sponsors
General Committee of Teaching Hospitals and Institutes, Egypt
5 trialsPhase 4504 people
1 trialPhase 4152 people
1 trialPhase 4108 people
1 trialPhase 4100 people
1 trialPhase 492 people
University of California, Davis
1 trialPhase 460 people
1 trialPhase 450 people
Hospital Civil Juan I. Menchaca
1 trialPhase 437 people
Latest
2 in 12 monthsResearch Square
Potential Therapeutic Effects of a GLP-1 Analogue on Blood Pressure in Morbidly Obese Patient: A Case Report
Preprint: case reportGLP-1 receptor agonists
AHA Scientific Sessions 2025 Abstract
Combination of Prolonged Water Fasting and Tirzepatide for Treatment of Refractory Morbid Obesity: Case Report
Case reportTirzepatide
ADA Scientific Sessions 2025 Abstract
Association of Obese Status and Low-Density Lipoprotein Cholesterol Target Achievement with All-Cause Mortaltiy Risk among Statin Users Aged 75 and Older According to Body Mass Index
Cohort study of 297,023 peoplePopulations
NPJ Aging and Mechanisms of Disease
Treatment of diabetic mice with the SGLT2 inhibitor TA-1887 antagonizes diabetic cachexia and decreases mortality
Experiments in miceInterventions
American Journal of Epidemiology
Epidemiology of sarcopenia among the elderly in New Mexico
Cross-sectional study of 883 peopleSarcopenia